HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.39 CNY | -4.79% |
|
-22.78% | -57.10% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,906 | 3,334 | 3,994 | 3,836 | 2,798 | 2,850 |
| Enterprise Value (EV) 1 | 5,095 | 4,361 | 5,162 | 4,537 | 3,215 | 3,431 |
| P/E ratio | 20.9 x | -3.78 x | -4.13 x | -23.4 x | -21.8 x | -13.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.51 x | 2.48 x | 4.55 x | 4.73 x | 3.33 x | 4.34 x |
| EV / Revenue | 1.97 x | 3.24 x | 5.88 x | 5.59 x | 3.82 x | 5.22 x |
| EV / EBITDA | 12.8 x | -8.4 x | -8.33 x | -21.2 x | 105 x | -52.1 x |
| EV / FCF | 22.2 x | 14 x | -69.2 x | 29 x | 17.1 x | 31.1 x |
| FCF Yield | 4.5% | 7.14% | -1.45% | 3.45% | 5.84% | 3.21% |
| Price to Book | 1.57 x | 2.1 x | 9.02 x | 12.5 x | 15.7 x | -57.6 x |
| Nbr of stocks (in thousands) | 879,774 | 879,774 | 879,774 | 879,774 | 879,774 | 879,774 |
| Reference price 2 | 4.440 | 3.790 | 4.540 | 4.360 | 3.180 | 3.240 |
| Announcement Date | 24/04/19 | 29/04/20 | 29/04/21 | 29/04/22 | 28/04/23 | 29/04/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2,586 | 1,344 | 877.9 | 811.2 | 840.7 | 656.9 |
| EBITDA 1 | 397.9 | -519.1 | -619.6 | -214.4 | 30.72 | -65.85 |
| EBIT 1 | 306.8 | -593.4 | -699.2 | -309.8 | -19.87 | -104.4 |
| Operating Margin | 11.87% | -44.15% | -79.64% | -38.19% | -2.36% | -15.89% |
| Earnings before Tax (EBT) 1 | 243.8 | -919.8 | -1,044 | -155.4 | -90.56 | -173.7 |
| Net income 1 | 186.8 | -882.8 | -969.9 | -163.7 | -128.2 | -215.1 |
| Net margin | 7.22% | -65.68% | -110.48% | -20.18% | -15.25% | -32.75% |
| EPS 2 | 0.2123 | -1.003 | -1.100 | -0.1860 | -0.1457 | -0.2445 |
| Free Cash Flow 1 | 229 | 311.4 | -74.62 | 156.6 | 187.7 | 110.2 |
| FCF margin | 8.86% | 23.17% | -8.5% | 19.3% | 22.33% | 16.78% |
| FCF Conversion (EBITDA) | 57.56% | - | - | - | 610.98% | - |
| FCF Conversion (Net income) | 122.61% | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 24/04/19 | 29/04/20 | 29/04/21 | 29/04/22 | 28/04/23 | 29/04/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 3.338 |
| Net margin | - |
| EPS 2 | 0.003800 |
| Dividend per Share | - |
| Announcement Date | 29/04/22 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,189 | 1,027 | 1,168 | 701 | 417 | 581 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.987 x | -1.978 x | -1.885 x | -3.271 x | 13.59 x | -8.819 x |
| Free Cash Flow 1 | 229 | 311 | -74.6 | 157 | 188 | 110 |
| ROE (net income / shareholders' equity) | 7.27% | -38.4% | -81.3% | -41.8% | -37.2% | -861% |
| ROA (Net income/ Total Assets) | 3.8% | -7.75% | -12.4% | -8.64% | -0.76% | -5.18% |
| Assets 1 | 4,917 | 11,398 | 7,813 | 1,894 | 16,830 | 4,152 |
| Book Value Per Share 2 | 2.820 | 1.810 | 0.5000 | 0.3500 | 0.2000 | -0.0600 |
| Cash Flow per Share 2 | 0.5800 | 0.4600 | 0.1900 | 0.2000 | 0.2100 | 0.0100 |
| Capex 1 | 171 | 114 | 96 | 38.1 | 13.5 | 10.4 |
| Capex / Sales | 6.62% | 8.46% | 10.94% | 4.7% | 1.61% | 1.59% |
| Announcement Date | 24/04/19 | 29/04/20 | 29/04/21 | 29/04/22 | 28/04/23 | 29/04/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -57.10% | 169M | |
| +45.82% | 765B | |
| +40.95% | 632B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.45% | 248B | |
| -0.78% | 219B | |
| +11.88% | 216B | |
| +5.90% | 164B |
- Stock Market
- Equities
- 000908 Stock
- Financials Hunan Jingfeng Pharmaceutical Co.,Ltd.
